As on Wednesday, Apyx Medical Corp (NASDAQ: APYX) got off with the flyer as it spiked 16.55% to $1.69, before settling in for the price of $1.45 at the close. Taking a more long-term approach, APYX posted a 52-week range of $0.97-$3.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 30.52% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -25.84%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -31.02%. This publicly-traded company’s shares outstanding now amounts to $34.64 million, simultaneously with a float of $31.55 million. The organization now has a market capitalization sitting at $63.61 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2534, while the 200-day Moving Average is $1.4239.
Apyx Medical Corp (APYX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Apyx Medical Corp’s current insider ownership accounts for 16.18%, in contrast to 33.92% institutional ownership. According to the most recent insider trade that took place on Aug 13 ’24, this organization’s Chief Financial Officer bought 5,336 shares at the rate of 1.13, making the entire transaction reach 6,030 in total value, affecting insider ownership by 7,836. Preceding that transaction, on Dec 12 ’23, Company’s Chief Financial Officer bought 2,500 for 2.19, making the whole transaction’s value amount to 5,475. This particular insider is now the holder of 2,500 in total.
Apyx Medical Corp (APYX) Earnings and Revenue Records
Apyx Medical Corp’s EPS decrease for this current 12-month fiscal period is -31.02% and is forecasted to reach -0.40 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.00% through the next 5 years, which can be compared against the -25.84% growth it accomplished over the previous five years trading on the market.
Apyx Medical Corp (NASDAQ: APYX) Trading Performance Indicators
Let’s observe the current performance indicators for Apyx Medical Corp (APYX). It’s Quick Ratio in the last reported quarter now stands at 4.52. The Stock has managed to achieve an average true range (ATR) of 0.13. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.31.
In the same vein, APYX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.82, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be -0.40 at the market close of one year from today.
Technical Analysis of Apyx Medical Corp (APYX)
Through scrutinizing the latest numbers posted by the [Apyx Medical Corp, APYX], it can be observed that its last 5-days Average volume of 58080.0 was lower the volume of 81011.0, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 90.00% While, its Average True Range was 0.1363.
Raw Stochastic average of Apyx Medical Corp (APYX) in the period of the previous 100 days is set at 98.64%, which indicates a major rise in contrast to 98.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 122.18% that was higher than 80.91% volatility it exhibited in the past 100-days period.
